Clinical trials recruiting in Krasnoyarsk, Russia

Phase breakdown

Conditions recruiting in Krasnoyarsk, Russia

Recruiting trials in Krasnoyarsk, Russia

• A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1
  NCT07292168 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants With Chronic Kidney Disease and High Proteinuria
  NCT06942910 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDeration
  NCT07052578 · Phase: Not specified · Ages: 18 Years and older · Sex: Male
• An Extension Study to Assess Impact of Multiple Sclerosis (MS) on Physical Function and Provide Continued Ocrelizumab Treatment
  NCT06675955 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Clinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Crohn's Disease
  NCT07078994 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)
  NCT06472310 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Clinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGistry Study
  NCT06521229 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female)
• Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)
  NCT04375800 · Phase: Phase 2 · Ages: 4 Weeks to 11 Years · Sex: All (male and female)
• Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia
  NCT06930859 · Phase: Not specified · Ages: 18 Years to 99 Years · Sex: All (male and female)
• ReAl-woRld Evaluation of tEzepelumab for Chronic rhinoSinusitis With Nasal Polyps in Russia
  NCT07399665 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Ulcerative Colitis
  NCT07080034 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.
  NCT03945968 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Krasnoyarsk, Russia?

12 recruiting trials have at least one study site in Krasnoyarsk, Russia.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.